Jeff Willis, MD, PhD: Faricimab Improves Fluid Outcomes in Eyes with nAMD
An analysis of the TENAYA/LUCERNE presented at ARVO 2023 suggests faricimab more rapidly improved anatomic outcomes in patients with nAMD compared to aflibercept.
Source: hcplive.com